The Patent Finder

Nobelpharma Co., Ltd.

11 patents currently held · Updated Nov 15, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jun 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 23, 2027
    The maintenance fee for Agent for regenerating tympanic membrane or external auditory canal (US 10,357,595) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
  • 1 fee due Apr 20, 2027
    The maintenance fee for Agent for regenerating tympanic membrane or external auditory canal (US 9,161,904) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,161,904Agent for regenerating tympanic membrane or external auditory canal
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,117,969Agent for regenerating tympanic membrane or external auditory canal
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,357,595Agent for regenerating tympanic membrane or external auditory canal
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,809,563Maleic acid salt of anti-prion compound, method for producing the same and pharmaceutical composition of the same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,813,765Voice Disorder Treatment Tool and Voice Disorder Treatment Set
In force
 · High confidence
In forceHigh confidence
US 11,051,985Preparation jig for tympanic membrane regenerating agent and preparation vessel for tympanic membrane regenerating agent
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,523,908Dysphonia treatment tool
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,517,424Tool for molding dysphonia treatment tool, and method for bending front piece of dysphonia treatment tool
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,773,403Scopolamine Compositions and Transdermal Patches Made Therefrom
In force
 · High confidence
In forceHigh confidence
US 12,746,232Patch for Alleviating or Treating Symptoms of Neurodegenerative Disease
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 3 patents in force now held by others · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited